Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deirdra R Terrell

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Transfusion|February 13, 2009
Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpuraKaren K Swisher, Deirdra R Terrell, Sara K Vesely, et al.
Transfusion|April 8, 2011
Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiencyDeirdra R Terrell, David G Motto, Johanna A Kremer Hovinga, et al.
American Journal of Hematology|February 5, 2010
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reportsDeirdra R Terrell, Laura A Beebe, Sara K Vesely, et al.
Plos One|February 7, 2018
A structural equation modeling approach to understanding pathways that connect socioeconomic status and smokingSydney A Martinez, Laura A Beebe, David M Thompson, et al.
Pediatric Blood & Cancer|June 5, 2013
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical featuresJessica A Reese, Darrshini S Muthurajah, Johanna A Kremer Hovinga, et al.
Medicina (Kaunas, Lithuania)|December 3, 2020
Immune Thrombocytopenia (ITP): Current Limitations in Patient ManagementDeirdra R Terrell, Cindy E Neunert, Nichola Cooper, et al.
Journal of Clinical Medicine|August 12, 2023
Patient-Reported Outcome Measures in Patients with Thrombotic Thrombocytopenic Purpura: A Systematic Review of the LiteratureAlexandre Soares Ferreira Junior, Morgana Pinheiro Maux Lessa, Samantha Kaplan, et al.
Journal of Thrombosis and Thrombolysis|March 28, 2018
Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologistsAllyson M Pishko, Mudi Misgav, Adam Cuker, et al.
Thrombosis and Haemostasis|March 31, 2010
Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured populationPeter M Wahl, Deirdra R Terrell, James N George, et al.
American Journal of Hematology|May 16, 2003
Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanerceptJ R McMinn, Stephen Cohen, Joseph Moore, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Transfusion|February 13, 2009
Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpuraKaren K Swisher, Deirdra R Terrell, Sara K Vesely, et al.
Transfusion|April 8, 2011
Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiencyDeirdra R Terrell, David G Motto, Johanna A Kremer Hovinga, et al.
American Journal of Hematology|February 5, 2010
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reportsDeirdra R Terrell, Laura A Beebe, Sara K Vesely, et al.
Plos One|February 7, 2018
A structural equation modeling approach to understanding pathways that connect socioeconomic status and smokingSydney A Martinez, Laura A Beebe, David M Thompson, et al.
Pediatric Blood & Cancer|June 5, 2013
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical featuresJessica A Reese, Darrshini S Muthurajah, Johanna A Kremer Hovinga, et al.
Medicina (Kaunas, Lithuania)|December 3, 2020
Immune Thrombocytopenia (ITP): Current Limitations in Patient ManagementDeirdra R Terrell, Cindy E Neunert, Nichola Cooper, et al.
Journal of Clinical Medicine|August 12, 2023
Patient-Reported Outcome Measures in Patients with Thrombotic Thrombocytopenic Purpura: A Systematic Review of the LiteratureAlexandre Soares Ferreira Junior, Morgana Pinheiro Maux Lessa, Samantha Kaplan, et al.
Journal of Thrombosis and Thrombolysis|March 28, 2018
Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologistsAllyson M Pishko, Mudi Misgav, Adam Cuker, et al.
Thrombosis and Haemostasis|March 31, 2010
Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured populationPeter M Wahl, Deirdra R Terrell, James N George, et al.
American Journal of Hematology|May 16, 2003
Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanerceptJ R McMinn, Stephen Cohen, Joseph Moore, et al.
Pageof 8